Current Support
NIH/NIAID (U24 AI179612), “The Children’s Allergy and Asthma Data Repository (CADRE)” (2024 – 2029). Singh, Co-Investigator
NIH/NIAID & National Jewish Health (UM1 AI151958), “Targeted investigation of microbiome 2 treat atopic dermatitis – TIME-2” (2024 – 2026). Singh, subaward PI
NIH/NIAID (UG3 OD035509), “Childhood Allergy and the NeOnatal Environment (CANOE) ECHO pediatric follow-up and new enrollment” (2023 – 2030). Singh, PI
NIH/NIAID & Johns Hopkins University (UM1 AI182034), “New horizons in the prevention and treatment of food allergy – Sunbeam” (2021 – 2031). Singh, subaward PI
NIH/NIAID (U24 AI152177), “A multiplexed micro scale assay for real time analysis of pediatric immune cell function” (2020 – 2026). Singh, Co-Investigator
Completed Support
Hatch Act Formula Fund & Food Allergy Research and Education, “Clinical research center of distinction in the FARE clinical network” (2019 – 2024). Singh, PI
NIH/Office of the director & Duke University (U2C OD023375), “ECHO Coordinating Center – Childhood Allergy and the NeOnatal Environment (CANOE)” (2019 – 2023). Singh, sub-award PI
NIH/Office of the director (UH3 OD023282), “Children’s Respiratory Research and Environment Workgroup (CREW)” (2018 – 2023). Singh, Co-Investigator
Collegium Internationale Allergologicum, “Travel grant” (2018). Singh, PI
NIH/NIAID (K23 AI100995), “S. aureus and regulatory t cells in the failure of oral tolerance” (2013 – 2019). Singh, PI
American Academy of Allergy, Asthma & Immunology, “2007 AAAAI/ATS GSK fellows career development award” (2007 – 2009). Singh, fellow